Past Projects and Accomplishments

Evaluating and Assessing

Evaluated market potential for an orphan drug, then prepared argumentation for the board and investors. This resulted in a young biotechnology firm extending its pipeline.

Identified several early stage licensing in options for a mid-size pharmaceutical group in a geographical area that had been unexplored by the group before.

Conducted due diligence on a biotechnology firm for a venture capital company, identifying industrial issues which had been overlooked.

Assessed opportunities for a joint venture in China and conducting negotiations with the cities, Ministry and local industries. This resulted in the construction of a production site.

Defining Strategy and Negotiating

One agreement was signed between a major Japanese corporation and a French service provider on a new technology platform, following identification of the service provider, initial approach and support of the negotiation process. Several research partnerships were similarly started throughout Europe.

Co-authored the business plan for a spin-off from a pharmaceutical group, convinced senior management, met potential investors: business unit sold for $ 30 million.

Wrote the business plan for a start-up biotechnology company that raised € 2 million.

Connecting and Resourcing

Found an industrial partner for clinical trials, for a young biotechnology firm developing a new product: the search was conducted in 4 continents, and two candidates were identified. According to the client, this work saved them 6 months in their development process.

Identified and assessed potential French distributors for a German manufacturer of laboratory equipment. The contract signed upon our recommendation has subsequently been renewed and has now run for more than 10 years.

Identified a partner for a European project. The client and the partner have since pursued other cooperation avenues.

Managing

Created and managed a marketing department for the largest division of a $2 billion group resulting from the acquisition of several family businesses. This included creating a corporate identity, implementing an effective sales reporting system to put an end to internal competition and to increase margins, developing a competitive watch, representing the group on the board of trade associations and developing a service-based culture which resulted in market share gains of 5 to 7% in highly competitive markets (Germany, Italy, Korea, China, etc.)

Open up new avenues, find new partnerships, and take your biotech company to the next level. We can help you make it happen.

Contact us today